Your cart is empty.
Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.
- Shop
- The Scene
-
About
About Tecan
Investors
Press Center
- Support
- Contact
- Life Sciences
- Diagnostics
- Partnering
- Language
Tecan Journal
Selected category: D300e
Back to overviewDriving the development of novel 3D cell-based assays
3D cell culture is an area of great interest in the drug development industry, as 3D models give a more accurate representation of how cells act in response to compounds in vivo. Merck’s Cellular Pharmacology Department specializes in the use of spheroid cell cultures to test various conditions and compounds of interest, and identify candidate drugs. Automation plays a vital role in this process, enabling high throughput screening of cell-based assays.
Developing novel influenza inhibitors
The VirPath laboratory is focused on the study of influenza and other respiratory viruses to identify new antiviral molecules and develop innovative vaccines. Digital dispensing and luminescence-based assays play an important role in the evaluation of viral growth in different experimental models.